APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Premarital Genetic Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Premarital Genetic Testing Market Outlook and Growth Opportunities 2026

Report ID 17421995044 June 2026213 pages

Choose your research edition.

Industry ResearchPremarital Genetic Testing Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Premarital Genetic Testing Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Premarital Genetic Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Premarital Genetic Testing Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Premarital Genetic Testing Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Premarital Genetic Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Premarital Genetic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Premarital Genetic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Premarital Genetic Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Premarital Genetic Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Premarital Genetic Testing market include NxGen MDx, LLC, OPKO Health, Gene by Gene, Sonic Genetics, MedGenome Labs, Centogene, LSI Medience, GC Genome and Illumina, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Premarital Genetic Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Premarital Genetic Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Premarital Genetic Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Premarital Genetic Testing market.

Premarital Genetic Testing Segment by Company

NxGen MDx, LLC

OPKO Health

Gene by Gene

Sonic Genetics

MedGenome Labs

Centogene

LSI Medience

GC Genome

Illumina

Fulgent Genetics

Natera

Clinical Labs

Eurofins Scientific

Myriad Genetics

Thermo Fisher Scientific

Genoma Group

SRL Inc.

Seegene

Huizhi Gene

My Baby Company

Invitae

Dian Diagnostics Group

Adicon

BGI

WuXi AppTec

Novogene

Berry Genomics

Kingmed Diagnostic

Zhongyuan Concord

AmoyDx

Premarital Genetic Testing Segment by Type

Single-Gene Genetic Disease Testing

Chromosomal Structural And Numerical Abnormality Testing

Polygenic Disease Risk Assessment

Mitochondrial And Maternal Genetic Testing

Pharmacogenomics And Functional Gene Testing

Premarital Genetic Testing Segment by Application

Male

Female

Premarital Genetic Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Premarital Genetic Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Premarital Genetic Testing key companies, revenue, market share, and recent developments.

3. To split the Premarital Genetic Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Premarital Genetic Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Premarital Genetic Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Premarital Genetic Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Premarital Genetic Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Premarital Genetic Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Premarital Genetic Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Premarital Genetic Testing industry.

Chapter 3: Detailed analysis of Premarital Genetic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Premarital Genetic Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Premarital Genetic Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Premarital Genetic Testing Industry Trends Table 2. Premarital Genetic Testing Industry Drivers Table 3. Premarital Genetic Testing Industry Opportunities and Challenges Table 4. Premarital Genetic Testing Industry Restraints Table 5. Global Premarital Genetic Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Premarital Genetic Testing Revenue Share by Company (2021-2026) Table 7. Global Premarital Genetic Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Premarital Genetic Testing Key Company Manufacturing Base & Headquarters Table 9. Global Premarital Genetic Testing Company, Product Type & Application Table 10. Global Premarital Genetic Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Premarital Genetic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Single-Gene Genetic Disease Testing Table 15. Significant Companies of Chromosomal Structural And Numerical Abnormality Testing Table 16. Significant Companies of Polygenic Disease Risk Assessment Table 17. Significant Companies of Mitochondrial And Maternal Genetic Testing Table 18. Significant Companies of Pharmacogenomics And Functional Gene Testing Table 19. Global Premarital Genetic Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Premarital Genetic Testing Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Premarital Genetic Testing Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Premarital Genetic Testing Sales Value Share by Type (2021-2026) Table 23. Global Premarital Genetic Testing Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Male Table 25. Significant Companies of Female Table 26. Global Premarital Genetic Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Premarital Genetic Testing Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Premarital Genetic Testing Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Premarital Genetic Testing Sales Value Share by Application (2021-2026) Table 30. Global Premarital Genetic Testing Sales Value Share by Application (2027-2032) Table 31. Global Premarital Genetic Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Premarital Genetic Testing Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Premarital Genetic Testing Sales Value Share by Region (2021-2026) Table 34. Global Premarital Genetic Testing Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Premarital Genetic Testing Sales Value Share by Region (2027-2032) Table 36. Global Premarital Genetic Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Premarital Genetic Testing Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Premarital Genetic Testing Sales Value Market Share by Country (2021-2026) Table 39. Global Premarital Genetic Testing Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Premarital Genetic Testing Sales Value Market Share by Country (2027-2032) Table 41. NxGen MDx, LLC Company Information Table 42. NxGen MDx, LLC Business Overview Table 43. NxGen MDx, LLC Premarital Genetic Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. NxGen MDx, LLC Premarital Genetic Testing Product Portfolio Table 45. NxGen MDx, LLC Recent Development Table 46. OPKO Health Company Information Table 47. OPKO Health Business Overview Table 48. OPKO Health Premarital Genetic Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. OPKO Health Premarital Genetic Testing Product Portfolio Table 50. OPKO Health Recent Development Table 51. Gene by Gene Company Information Table 52. Gene by Gene Business Overview Table 53. Gene by Gene Premarital Genetic Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Gene by Gene Premarital Genetic Testing Product Portfolio Table 55. Gene by Gene Recent Development Table 56. Sonic Genetics Company Information Table 57. Sonic Genetics Business Overview Table 58. Sonic Genetics Premarital Genetic Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Sonic Genetics Premarital Genetic Testing Product Portfolio Table 60. Sonic Genetics Recent Development Table 61. MedGenome Labs Company Information Table 62. MedGenome Labs Business Overview Table 63. MedGenome Labs Premarital Genetic Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. MedGenome Labs Premarital Genetic Testing Product Portfolio Table 65. MedGenome Labs Recent Development Table 66. Centogene Company Information Table 67. Centogene Business Overview Table 68. Centogene Premarital Genetic Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Centogene Premarital Genetic Testing Product Portfolio Table 70. Centogene Recent Development Table 71. LSI Medience Company Information Table 72. LSI Medience Business Overview Table 73. LSI Medience Premarital Genetic Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. LSI Medience Premarital Genetic Testing Product Portfolio Table 75. LSI Medience Recent Development Table 76. GC Genome Company Information Table 77. GC Genome Business Overview Table 78. GC Genome Premarital Genetic Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. GC Genome Premarital Genetic Testing Product Portfolio Table 80. GC Genome Recent Development Table 81. Illumina Company Information Table 82. Illumina Business Overview Table 83. Illumina Premarital Genetic Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Illumina Premarital Genetic Testing Product Portfolio Table 85. Illumina Recent Development Table 86. Fulgent Genetics Company Information Table 87. Fulgent Genetics Business Overview Table 88. Fulgent Genetics Premarital Genetic Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Fulgent Genetics Premarital Genetic Testing Product Portfolio Table 90. Fulgent Genetics Recent Development Table 91. Natera Company Information Table 92. Natera Business Overview Table 93. Natera Premarital Genetic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Natera Premarital Genetic Testing Product Portfolio Table 95. Natera Recent Development Table 96. Clinical Labs Company Information Table 97. Clinical Labs Business Overview Table 98. Clinical Labs Premarital Genetic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Clinical Labs Premarital Genetic Testing Product Portfolio Table 100. Clinical Labs Recent Development Table 101. Eurofins Scientific Company Information Table 102. Eurofins Scientific Business Overview Table 103. Eurofins Scientific Premarital Genetic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Eurofins Scientific Premarital Genetic Testing Product Portfolio Table 105. Eurofins Scientific Recent Development Table 106. Myriad Genetics Company Information Table 107. Myriad Genetics Business Overview Table 108. Myriad Genetics Premarital Genetic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Myriad Genetics Premarital Genetic Testing Product Portfolio Table 110. Myriad Genetics Recent Development Table 111. Thermo Fisher Scientific Company Information Table 112. Thermo Fisher Scientific Business Overview Table 113. Thermo Fisher Scientific Premarital Genetic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Thermo Fisher Scientific Premarital Genetic Testing Product Portfolio Table 115. Thermo Fisher Scientific Recent Development Table 116. Genoma Group Company Information Table 117. Genoma Group Business Overview Table 118. Genoma Group Premarital Genetic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Genoma Group Premarital Genetic Testing Product Portfolio Table 120. Genoma Group Recent Development Table 121. SRL Inc. Company Information Table 122. SRL Inc. Business Overview Table 123. SRL Inc. Premarital Genetic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. SRL Inc. Premarital Genetic Testing Product Portfolio Table 125. SRL Inc. Recent Development Table 126. Seegene Company Information Table 127. Seegene Business Overview Table 128. Seegene Premarital Genetic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Seegene Premarital Genetic Testing Product Portfolio Table 130. Seegene Recent Development Table 131. Huizhi Gene Company Information Table 132. Huizhi Gene Business Overview Table 133. Huizhi Gene Premarital Genetic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Huizhi Gene Premarital Genetic Testing Product Portfolio Table 135. Huizhi Gene Recent Development Table 136. My Baby Company Company Information Table 137. My Baby Company Business Overview Table 138. My Baby Company Premarital Genetic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. My Baby Company Premarital Genetic Testing Product Portfolio Table 140. My Baby Company Recent Development Table 141. Invitae Company Information Table 142. Invitae Business Overview Table 143. Invitae Premarital Genetic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Invitae Premarital Genetic Testing Product Portfolio Table 145. Invitae Recent Development Table 146. Dian Diagnostics Group Company Information Table 147. Dian Diagnostics Group Business Overview Table 148. Dian Diagnostics Group Premarital Genetic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. Dian Diagnostics Group Premarital Genetic Testing Product Portfolio Table 150. Dian Diagnostics Group Recent Development Table 151. Adicon Company Information Table 152. Adicon Business Overview Table 153. Adicon Premarital Genetic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Adicon Premarital Genetic Testing Product Portfolio Table 155. Adicon Recent Development Table 156. BGI Company Information Table 157. BGI Business Overview Table 158. BGI Premarital Genetic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. BGI Premarital Genetic Testing Product Portfolio Table 160. BGI Recent Development Table 161. WuXi AppTec Company Information Table 162. WuXi AppTec Business Overview Table 163. WuXi AppTec Premarital Genetic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 164. WuXi AppTec Premarital Genetic Testing Product Portfolio Table 165. WuXi AppTec Recent Development Table 166. Novogene Company Information Table 167. Novogene Business Overview Table 168. Novogene Premarital Genetic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 169. Novogene Premarital Genetic Testing Product Portfolio Table 170. Novogene Recent Development Table 171. Berry Genomics Company Information Table 172. Berry Genomics Business Overview Table 173. Berry Genomics Premarital Genetic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 174. Berry Genomics Premarital Genetic Testing Product Portfolio Table 175. Berry Genomics Recent Development Table 176. Kingmed Diagnostic Company Information Table 177. Kingmed Diagnostic Business Overview Table 178. Kingmed Diagnostic Premarital Genetic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 179. Kingmed Diagnostic Premarital Genetic Testing Product Portfolio Table 180. Kingmed Diagnostic Recent Development Table 181. Zhongyuan Concord Company Information Table 182. Zhongyuan Concord Business Overview Table 183. Zhongyuan Concord Premarital Genetic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 184. Zhongyuan Concord Premarital Genetic Testing Product Portfolio Table 185. Zhongyuan Concord Recent Development Table 186. AmoyDx Company Information Table 187. AmoyDx Business Overview Table 188. AmoyDx Premarital Genetic Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 189. AmoyDx Premarital Genetic Testing Product Portfolio Table 190. AmoyDx Recent Development Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Premarital Genetic Testing Product Image Figure 2. Global Premarital Genetic Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Premarital Genetic Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Premarital Genetic Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Single-Gene Genetic Disease Testing Image Figure 8. Chromosomal Structural And Numerical Abnormality Testing Image Figure 9. Polygenic Disease Risk Assessment Image Figure 10. Mitochondrial And Maternal Genetic Testing Image Figure 11. Pharmacogenomics And Functional Gene Testing Image Figure 12. Global Premarital Genetic Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Premarital Genetic Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Premarital Genetic Testing Sales Value Share by Type (2021-2032) Figure 15. Male Image Figure 16. Female Image Figure 17. Global Premarital Genetic Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Premarital Genetic Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Premarital Genetic Testing Sales Value Share by Application (2021-2032) Figure 20. Global Premarital Genetic Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Premarital Genetic Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Premarital Genetic Testing Sales Value (2021-2032) & (US$ Million) Figure 23. North America Premarital Genetic Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Premarital Genetic Testing Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Premarital Genetic Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Premarital Genetic Testing Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Premarital Genetic Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Premarital Genetic Testing Sales Value (2021-2032) & (US$ Million) Figure 29. South America Premarital Genetic Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Premarital Genetic Testing Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Premarital Genetic Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Premarital Genetic Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Single-Gene Genetic Disease Testing
  • Chromosomal Structural And Numerical Abnormality Testing
  • Polygenic Disease Risk Assessment
  • Mitochondrial And Maternal Genetic Testing
  • Pharmacogenomics And Functional Gene Testing
Applications
  • Male
  • Female
Companies covered
  • NxGen MDx, LLC
  • OPKO Health
  • Gene by Gene
  • Sonic Genetics
  • MedGenome Labs
  • Centogene
  • LSI Medience
  • GC Genome
  • Illumina
  • Fulgent Genetics
  • Natera
  • Clinical Labs
  • Eurofins Scientific
  • Myriad Genetics
  • Thermo Fisher Scientific
  • Genoma Group
  • SRL Inc.
  • Seegene
  • Huizhi Gene
  • My Baby Company
  • Invitae
  • Dian Diagnostics Group
  • Adicon
  • BGI
  • WuXi AppTec
  • Novogene
  • Berry Genomics
  • Kingmed Diagnostic
  • Zhongyuan Concord
  • AmoyDx

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Premarital Genetic Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Premarital Genetic Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Premarital Genetic Testing Market Dynamics
  1. 2.1 Premarital Genetic Testing Industry Trends
  2. 2.2 Premarital Genetic Testing Industry Drivers
  3. 2.3 Premarital Genetic Testing Industry Opportunities and Challenges
  4. 2.4 Premarital Genetic Testing Industry Restraints
3 Premarital Genetic Testing Market by Company
  1. 3.1 Global Premarital Genetic Testing Company Revenue Ranking in 2025
  2. 3.2 Global Premarital Genetic Testing Revenue by Company (2021-2026)
  3. 3.3 Global Premarital Genetic Testing Company Ranking (2024-2026)
  4. 3.4 Global Premarital Genetic Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Premarital Genetic Testing Company Product Type and Application
  6. 3.6 Global Premarital Genetic Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Premarital Genetic Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Premarital Genetic Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Premarital Genetic Testing Market by Type
  1. 4.1 Premarital Genetic Testing Type Introduction
  2. 4.1.1 Single-Gene Genetic Disease Testing
  3. 4.1.2 Chromosomal Structural And Numerical Abnormality Testing
  4. 4.1.3 Polygenic Disease Risk Assessment
  5. 4.1.4 Mitochondrial And Maternal Genetic Testing
  6. 4.1.5 Pharmacogenomics And Functional Gene Testing
  7. 4.2 Global Premarital Genetic Testing Sales Value by Type
  8. 4.2.1 Global Premarital Genetic Testing Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Premarital Genetic Testing Sales Value by Type (2021-2032)
  10. 4.2.3 Global Premarital Genetic Testing Sales Value Share by Type (2021-2032)
5 Premarital Genetic Testing Market by Application
  1. 5.1 Premarital Genetic Testing Application Introduction
  2. 5.1.1 Male
  3. 5.1.2 Female
  4. 5.2 Global Premarital Genetic Testing Sales Value by Application
  5. 5.2.1 Global Premarital Genetic Testing Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Premarital Genetic Testing Sales Value by Application (2021-2032)
  7. 5.2.3 Global Premarital Genetic Testing Sales Value Share by Application (2021-2032)
6 Premarital Genetic Testing Regional Value Analysis
  1. 6.1 Global Premarital Genetic Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Premarital Genetic Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Premarital Genetic Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Premarital Genetic Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Premarital Genetic Testing Sales Value (2021-2032)
  7. 6.3.2 North America Premarital Genetic Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Premarital Genetic Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Premarital Genetic Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Premarital Genetic Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Premarital Genetic Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Premarital Genetic Testing Sales Value (2021-2032)
  16. 6.6.2 South America Premarital Genetic Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Premarital Genetic Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Premarital Genetic Testing Sales Value Share by Country, 2025 VS 2032
7 Premarital Genetic Testing Country-level Value Analysis
  1. 7.1 Global Premarital Genetic Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Premarital Genetic Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Premarital Genetic Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Premarital Genetic Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Premarital Genetic Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Premarital Genetic Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Premarital Genetic Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 NxGen MDx, LLC
  2. 8.1.1 NxGen MDx, LLC Company Information
  3. 8.1.2 NxGen MDx, LLC Business Overview
  4. 8.1.3 NxGen MDx, LLC Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 NxGen MDx, LLC Premarital Genetic Testing Product Portfolio
  6. 8.1.5 NxGen MDx, LLC Recent Developments
  7. 8.2 OPKO Health
  8. 8.2.1 OPKO Health Company Information
  9. 8.2.2 OPKO Health Business Overview
  10. 8.2.3 OPKO Health Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 OPKO Health Premarital Genetic Testing Product Portfolio
  12. 8.2.5 OPKO Health Recent Developments
  13. 8.3 Gene by Gene
  14. 8.3.1 Gene by Gene Company Information
  15. 8.3.2 Gene by Gene Business Overview
  16. 8.3.3 Gene by Gene Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Gene by Gene Premarital Genetic Testing Product Portfolio
  18. 8.3.5 Gene by Gene Recent Developments
  19. 8.4 Sonic Genetics
  20. 8.4.1 Sonic Genetics Company Information
  21. 8.4.2 Sonic Genetics Business Overview
  22. 8.4.3 Sonic Genetics Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sonic Genetics Premarital Genetic Testing Product Portfolio
  24. 8.4.5 Sonic Genetics Recent Developments
  25. 8.5 MedGenome Labs
  26. 8.5.1 MedGenome Labs Company Information
  27. 8.5.2 MedGenome Labs Business Overview
  28. 8.5.3 MedGenome Labs Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MedGenome Labs Premarital Genetic Testing Product Portfolio
  30. 8.5.5 MedGenome Labs Recent Developments
  31. 8.6 Centogene
  32. 8.6.1 Centogene Company Information
  33. 8.6.2 Centogene Business Overview
  34. 8.6.3 Centogene Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Centogene Premarital Genetic Testing Product Portfolio
  36. 8.6.5 Centogene Recent Developments
  37. 8.7 LSI Medience
  38. 8.7.1 LSI Medience Company Information
  39. 8.7.2 LSI Medience Business Overview
  40. 8.7.3 LSI Medience Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 LSI Medience Premarital Genetic Testing Product Portfolio
  42. 8.7.5 LSI Medience Recent Developments
  43. 8.8 GC Genome
  44. 8.8.1 GC Genome Company Information
  45. 8.8.2 GC Genome Business Overview
  46. 8.8.3 GC Genome Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GC Genome Premarital Genetic Testing Product Portfolio
  48. 8.8.5 GC Genome Recent Developments
  49. 8.9 Illumina
  50. 8.9.1 Illumina Company Information
  51. 8.9.2 Illumina Business Overview
  52. 8.9.3 Illumina Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Illumina Premarital Genetic Testing Product Portfolio
  54. 8.9.5 Illumina Recent Developments
  55. 8.10 Fulgent Genetics
  56. 8.10.1 Fulgent Genetics Company Information
  57. 8.10.2 Fulgent Genetics Business Overview
  58. 8.10.3 Fulgent Genetics Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Fulgent Genetics Premarital Genetic Testing Product Portfolio
  60. 8.10.5 Fulgent Genetics Recent Developments
  61. 8.11 Natera
  62. 8.11.1 Natera Company Information
  63. 8.11.2 Natera Business Overview
  64. 8.11.3 Natera Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Natera Premarital Genetic Testing Product Portfolio
  66. 8.11.5 Natera Recent Developments
  67. 8.12 Clinical Labs
  68. 8.12.1 Clinical Labs Company Information
  69. 8.12.2 Clinical Labs Business Overview
  70. 8.12.3 Clinical Labs Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Clinical Labs Premarital Genetic Testing Product Portfolio
  72. 8.12.5 Clinical Labs Recent Developments
  73. 8.13 Eurofins Scientific
  74. 8.13.1 Eurofins Scientific Company Information
  75. 8.13.2 Eurofins Scientific Business Overview
  76. 8.13.3 Eurofins Scientific Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Eurofins Scientific Premarital Genetic Testing Product Portfolio
  78. 8.13.5 Eurofins Scientific Recent Developments
  79. 8.14 Myriad Genetics
  80. 8.14.1 Myriad Genetics Company Information
  81. 8.14.2 Myriad Genetics Business Overview
  82. 8.14.3 Myriad Genetics Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Myriad Genetics Premarital Genetic Testing Product Portfolio
  84. 8.14.5 Myriad Genetics Recent Developments
  85. 8.15 Thermo Fisher Scientific
  86. 8.15.1 Thermo Fisher Scientific Company Information
  87. 8.15.2 Thermo Fisher Scientific Business Overview
  88. 8.15.3 Thermo Fisher Scientific Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Thermo Fisher Scientific Premarital Genetic Testing Product Portfolio
  90. 8.15.5 Thermo Fisher Scientific Recent Developments
  91. 8.16 Genoma Group
  92. 8.16.1 Genoma Group Company Information
  93. 8.16.2 Genoma Group Business Overview
  94. 8.16.3 Genoma Group Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Genoma Group Premarital Genetic Testing Product Portfolio
  96. 8.16.5 Genoma Group Recent Developments
  97. 8.17 SRL Inc.
  98. 8.17.1 SRL Inc. Company Information
  99. 8.17.2 SRL Inc. Business Overview
  100. 8.17.3 SRL Inc. Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 SRL Inc. Premarital Genetic Testing Product Portfolio
  102. 8.17.5 SRL Inc. Recent Developments
  103. 8.18 Seegene
  104. 8.18.1 Seegene Company Information
  105. 8.18.2 Seegene Business Overview
  106. 8.18.3 Seegene Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Seegene Premarital Genetic Testing Product Portfolio
  108. 8.18.5 Seegene Recent Developments
  109. 8.19 Huizhi Gene
  110. 8.19.1 Huizhi Gene Company Information
  111. 8.19.2 Huizhi Gene Business Overview
  112. 8.19.3 Huizhi Gene Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Huizhi Gene Premarital Genetic Testing Product Portfolio
  114. 8.19.5 Huizhi Gene Recent Developments
  115. 8.20 My Baby Company
  116. 8.20.1 My Baby Company Company Information
  117. 8.20.2 My Baby Company Business Overview
  118. 8.20.3 My Baby Company Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  119. 8.20.4 My Baby Company Premarital Genetic Testing Product Portfolio
  120. 8.20.5 My Baby Company Recent Developments
  121. 8.21 Invitae
  122. 8.21.1 Invitae Company Information
  123. 8.21.2 Invitae Business Overview
  124. 8.21.3 Invitae Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Invitae Premarital Genetic Testing Product Portfolio
  126. 8.21.5 Invitae Recent Developments
  127. 8.22 Dian Diagnostics Group
  128. 8.22.1 Dian Diagnostics Group Company Information
  129. 8.22.2 Dian Diagnostics Group Business Overview
  130. 8.22.3 Dian Diagnostics Group Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Dian Diagnostics Group Premarital Genetic Testing Product Portfolio
  132. 8.22.5 Dian Diagnostics Group Recent Developments
  133. 8.23 Adicon
  134. 8.23.1 Adicon Company Information
  135. 8.23.2 Adicon Business Overview
  136. 8.23.3 Adicon Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Adicon Premarital Genetic Testing Product Portfolio
  138. 8.23.5 Adicon Recent Developments
  139. 8.24 BGI
  140. 8.24.1 BGI Company Information
  141. 8.24.2 BGI Business Overview
  142. 8.24.3 BGI Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  143. 8.24.4 BGI Premarital Genetic Testing Product Portfolio
  144. 8.24.5 BGI Recent Developments
  145. 8.25 WuXi AppTec
  146. 8.25.1 WuXi AppTec Company Information
  147. 8.25.2 WuXi AppTec Business Overview
  148. 8.25.3 WuXi AppTec Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  149. 8.25.4 WuXi AppTec Premarital Genetic Testing Product Portfolio
  150. 8.25.5 WuXi AppTec Recent Developments
  151. 8.26 Novogene
  152. 8.26.1 Novogene Company Information
  153. 8.26.2 Novogene Business Overview
  154. 8.26.3 Novogene Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Novogene Premarital Genetic Testing Product Portfolio
  156. 8.26.5 Novogene Recent Developments
  157. 8.27 Berry Genomics
  158. 8.27.1 Berry Genomics Company Information
  159. 8.27.2 Berry Genomics Business Overview
  160. 8.27.3 Berry Genomics Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Berry Genomics Premarital Genetic Testing Product Portfolio
  162. 8.27.5 Berry Genomics Recent Developments
  163. 8.28 Kingmed Diagnostic
  164. 8.28.1 Kingmed Diagnostic Company Information
  165. 8.28.2 Kingmed Diagnostic Business Overview
  166. 8.28.3 Kingmed Diagnostic Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Kingmed Diagnostic Premarital Genetic Testing Product Portfolio
  168. 8.28.5 Kingmed Diagnostic Recent Developments
  169. 8.29 Zhongyuan Concord
  170. 8.29.1 Zhongyuan Concord Company Information
  171. 8.29.2 Zhongyuan Concord Business Overview
  172. 8.29.3 Zhongyuan Concord Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  173. 8.29.4 Zhongyuan Concord Premarital Genetic Testing Product Portfolio
  174. 8.29.5 Zhongyuan Concord Recent Developments
  175. 8.30 AmoyDx
  176. 8.30.1 AmoyDx Company Information
  177. 8.30.2 AmoyDx Business Overview
  178. 8.30.3 AmoyDx Premarital Genetic Testing Revenue and Gross Margin (2021-2026)
  179. 8.30.4 AmoyDx Premarital Genetic Testing Product Portfolio
  180. 8.30.5 AmoyDx Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst